Back to Search Start Over

Bi-level VNS therapy with different therapy modes at night and daytime improves seizures and quality of life in a patient with drug-resistant epilepsy.

Authors :
Voges BR
Source :
Epilepsy & behavior reports [Epilepsy Behav Rep] 2023 Nov 07; Vol. 24, pp. 100633. Date of Electronic Publication: 2023 Nov 07 (Print Publication: 2023).
Publication Year :
2023

Abstract

Induction or aggravation of sleep apnea is a known side effect of vagus nerve stimulation (VNS). We report the case of a 44 year old male with drug-resistant epilepsy and depression who did not experience any seizure reduction after 1 year of VNS but a worsening of depression and daytime sleepiness. After confirming VNS-associated sleep apnea we started the first bi-level VNS therapy with standard VNS settings during daytime and reduced settings during nighttime. Anti-seizure medication remained unchanged. Within 12 months his seizure frequency was reduced by 90 % and his depression improved, permitting a cessation of his antidepressant medication. The observations made in this case have contributed to the manufacturer of VNS developing new generator models that can automatically provide bi-level VNS.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (© 2023 The Author.)

Details

Language :
English
ISSN :
2589-9864
Volume :
24
Database :
MEDLINE
Journal :
Epilepsy & behavior reports
Publication Type :
Report
Accession number :
38045989
Full Text :
https://doi.org/10.1016/j.ebr.2023.100633